Introduction Bronchiectasis (BC) is a multidimensional and etiologically diverse disease
and, therefore, no single parameter can be used to determine its overall severity and …

Bronchiectasis is a heterogeneous disease in terms of its clinical and functional
presentation. Some isolated parameters have been used to assess the severity of …

Bronchiectasis is a chronic lung disease associated with structurally abnormal bronchi,
clinically manifested by a persistent wet/productive cough, airway infections and recurrent …

Objective: To investigate the efficacy and feasibility of home-based inspiratory muscle
training in patients with bronchiectasis. Design: A prospective, single-blind, randomized …

Patients with bronchiectasis often have impaired quality of life (QoL), which deteriorates with
exacerbations. The aim of this study was to investigate changes in QoL and how these were …

Background There is minimal literature available on the long‐term outcome of pediatric non‐
cystic fibrosis (CF) bronchiectasis. Aim To document 5‐year outcomes of children with chest …

Bronchiectasis is characterised by hypersecretion and impaired clearance of mucus. A 400-
mg dose of inhaled mannitol improves mucus clearance however, the effect of other doses is …

Background The aim was to measure symptoms of depression and anxiety in patients with
bronchiectasis and evaluate their relationship with a Mediterranean diet. Methods This cross …

Background and objective To explore the effect of long‐term therapy with azithromycin in
regards to airway oxidative stress markers in exhaled breath condensate (EBC) of adult …

Objective: To characterize a population of patients with bronchiectasis, correlating clinical,
radiological, and functional aspects with the severity of dyspnea. Methods: This was a cross …